Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric…
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment…
Read More...
Read More...
